A new study found that certain types of diabetes drugs could be linked to a fatal genital infection.
The study, which was published in the Annals of Medicine on May 7, looked at the ties between the sodium-glucose cotransporter-2 inhibitors (SGLT2) used in type 2 diabetes medicine and a genital infection called Fournier gangrene, which affects the genitals or genital area, according to the National Organization for Rare Disorders (NORD).
The “rare urologic emergency” is characterized as a necrotizing infection which kills body tissue and can cause inflammation in the tissue under the skin, according to the Centers for Disease Control and Prevention (CDC). It’s also commonly known as “flesh-eating bacteria” and its symptoms include fever, malaise, and moderate to severe pain and swelling in the genital and rectal areas, according to NORD.
The Food and Drug Administration (FDA) identified 55 cases of Fournier gangrene from patients who…
Subscribe to The North Star
Subscribe for $10 a month to gain access to this and many more articles from The North Star.
Do you already have an account? Log In